Q150 (Quetiapine Fumarate Extended-Release 150 mg)
Pill with imprint Q150 is White, Capsule-shape and has been identified as Quetiapine Fumarate Extended-Release 150 mg. It is supplied by Mallinckrodt Inc.
Quetiapine is used in the treatment of bipolar disorder; schizoaffective disorder; schizophrenia; depression; major depressive disorder and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Quetiapine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Q150
Quetiapine Fumarate Extended-Release
- Imprint
- Q150
- Strength
- 150 mg
- Color
- White
- Size
- 15.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Atypical antipsychotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mallinckrodt Inc.
- National Drug Code (NDC)
- 00406-1181
- Inactive Ingredients
-
lactose anhydrous,
ethylcellulose (100 mPa.s),
microcrystalline cellulose,
hydroxyethyl cellulose (4000 mpa.s at 1%),
magnesium stearate,
lactose monohydrate,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
More about quetiapine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (1,981)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: atypical antipsychotics
Patient resources
- Drug Information
- Quetiapine (Advanced Reading)
- Quetiapine Extended-Release Tablets
- Quetiapine Tablets
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.